Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease

NCT02207088 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C
Hepatitis C Virus
Compensated Cirrhosis
Severe Renal Impairment
End-stage Renal Disease

Interventions

DRUG: ombitasvir/paritaprevir/ritonavir
DRUG: dasabuvir
DRUG: Ribavirin

Sponsor

AbbVie